The emerging role of Hippo signaling in neurodegeneration
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Neurodegeneration refers to the complex process of progressive degeneration or neuronal apoptosis leading to a set of incurable and debilitating conditions. Physiologically, apoptosis is important in proper growth and development. However, aberrant and unrestricted apoptosis can lead to a variety of degenerative conditions including neurodegenerative diseases. Although dysregulated apoptosis has been implicated in various neurodegenerative disorders, the triggers and molecular mechanisms underlying such untimely and faulty apoptosis are still unknown. Hippo signaling pathway is one such apoptosis‐regulating mechanism that has remained evolutionarily conserved from Drosophila to mammals. This pathway has gained a lot of attention for its tumor‐suppressing task, but recent studies have emphasized the soaring role of this pathway in inflaming neurodegeneration. In addition, strategies promoting inactivation of this pathway have aided in the rescue of neurons from anomalous apoptosis. So, a thorough understanding of the relationship between the Hippo pathway and neurodegeneration may serve as a guide for the development of therapy for various degenerative diseases. The current review focuses on the mechanism of the Hippo signaling pathway, its upstream and downstream regulatory molecules, and its role in the genesis of numerous neurodegenerative diseases. The recent efforts employing the Hippo pathway components as targets for checking neurodegeneration have also been highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
Programmed Cell Death in Animal Development and Disease
Fuchs, Y., & Steller, H. (2011) · Cell · doi:10.1016/j.cell.2011.10.033 · Cited by 1,915 · cited 1×
“Throughout the process of intrauterine de‐ velopment, apoptosis controls cell number, gives an ample size and shape to the organs and eliminates unwanted cells from the body (Fuchs & Steller, 2011).”
BackgroundMechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667 · cited 3×
“When LATS phosphorylates Ser127 of YAP1 and Ser89 of TAZ in humans (Ser168 of Yki in Drosophila), it creates a binding site on the YAP proteins for 14‐3‐3 proteins, which promotes their cytoplasmic re‐ tention (Dong et al., 2007; Meng et al., 2016).”
BackgroundHippo pathway effector Yap promotes cardiac regeneration
Xin, M., Kim, Y., Sutherland, L. B., Murakami, M., Qi, X., McAnally, J., Porrello, E. R., Mahmoud, A. I., Tan, W., Shelton, J. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313192110 · Cited by 895
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2014 · Cited by 874
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843 · cited 2×
“Such interactions of YAP induce expression of proapoptotic genes like BAX and thus initi‐ ate apoptosis of the cell (Basu et al., 2003; Gong et al., 1999; Levy, Adamovich, Reuven, & Shaul, 2008; Matallanas et al., 2007) The role of Hippo signaling in neuronal death came into the limelight after the…”
BackgroundXu, T., Wang, W., Zhang, S., Stewart, R. A., & Yu, W. (1995) · Development · doi:10.1242/dev.121.4.1053 · Cited by 799
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Varelas, X. (2014) · Development · doi:10.1242/dev.102376 · Cited by 665 · cited 1×
“The YAP is responsible for the transcription of a number of cell cycle regulators like E2F1 and CYCE, some growth‐promoting genes like c‐Myc, and inhibitors of apoptosis like Birc3 and Diap1, all of which target tissue overgrowth (Dong et al., 2007; Huang et al., 2005; Varelas, 2014).”
BackgroundThe Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208445 · Cited by 584 · cited 6×
“Studies have shown that LATS1/2 also coor‐ dinates with the effectors of the proapoptotic pathway.”
BackgroundInfluentialCellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Mo, J.-S., Meng, Z., Kim, Y. C., Park, H. W., Hansen, C. G., Kim, S., Lim, D.-S., & Guan, K.-L. (2015) · Nature Cell Biology · doi:10.1038/ncb3111 · Cited by 557
Liu, C.-Y., Zha, Z.-Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S. W., Lim, C. J., Hong, W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152942 · Cited by 525
DeRan, M., Yang, J., Shen, C.-H., Peters, E. C., Fitamant, J., Chan, P., Hsieh, M., Zhu, S., Asara, J. M., Zheng, B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.036 · Cited by 316 · cited 9×
“Energy stress regulates hippo‐YAP signaling involving AMPK‐mediated regulation of angiomotin‐like 1 protein.”
BackgroundInfluentialChen, S. N., Gurha, P., Lombardi, R., Ruggiero, A., Willerson, J. T., & Marian, A. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.302810 · Cited by 275 · cited 1×
“…disorders like polycystic ovarian syndrome and primary ovarian in‐ sufficiency are some of the common degenerative disorders associ‐ ated with the hyperactivated Hippo signaling pathway (Ardestani & Maedler, 2018; Ardestani et al., 2014; Chen et al., 2014; Kawamura et al., 2013; Wang & Wang, 2016).”
BackgroundProgrammed Cell Death in Neurodevelopment
Yamaguchi, Y., & Miura, M. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.019 · Cited by 258 · cited 1×
“Aside from this embryonic regulation, vari‐ ous other physiological processes like defense mechanism‐related immune reactions and proper maintenance of neuronal circuitry are also under the strict control of apoptosis (Nagata & Tanaka, 2017; Yamaguchi & Miura, 2015).”
BackgroundHippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration
Lu, L., Finegold, M. J., & Johnson, R. L. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.205 · Cited by 190
Liberski, P. P., Sikorska, B., Bratosiewicz-Wasik, J., Carleton Gajdusek, D., & Brown, P. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.016 · Cited by 125
Zheng, Y., Liu, B., Wang, L., Lei, H., Pulgar Prieto, K. D., & Pan, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.076 · Cited by 110 · cited 10×
“In contrast, a protein phosphatase PP2A complex called STRIPAK (Bae et al., 2017; Praskova et al., 2004; Zheng et al., 2017), Dachsous– Fat system (Irvine & Harvey, 2015; Mao et al.”
BackgroundInfluentialTimm, T., Balusamy, K., Li, X., Biernat, J., Mandelkow, E., & Mandelkow, E.-M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706596200 · Cited by 95 · cited 1×
“…Tau proteins at several sites via the participation of microtubule affinity‐regulating kinase‐activating kinase (MARKK) or microtubule‐ associated protein (MAP), which may promote the generation of more tau aggregates and hence aggravate the AD condition (Johne et al., 2008; Timm et al., 2008).”
BackgroundHIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
Xiang, L., Gilkes, D. M., Hu, H., Luo, W., Bullen, J. W., Liang, H., & Semenza, G. L. (2015) · Oncotarget · doi:10.18632/oncotarget.4190 · Cited by 73
Label-free quantitative proteomic analysis of the YAP/TAZ interactome
Kohli, P., Bartram, M. P., Habbig, S., Pahmeyer, C., Lamkemeyer, T., Benzing, T., Schermer, B., & Rinschen, M. M. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00339.2013 · Cited by 61 · cited 1×
“RASSF1A, RASSF7, and RASSF8 have been reported to directly interact with YAP1; however, whether such interaction leads to the activation of proapoptotic pathways is yet to be answered (Dubois et al., 2016; Kohli et al., 2014).”
BackgroundLiu, B., Sun, L.-H., Huang, Y.-F., Guo, L.-J., & Luo, L.-S. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.12.015 · Cited by 29
Cited by
Mob Family Proteins: Regulatory Partners in Hippo and Hippo-Like Intracellular Signaling Pathways
Duhart, J. C., & Raftery, L. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00161 · Cited by 33
Pounders, J., Hill, E. J., Hooper, D., Zhang, X., Biesiada, J., Kuhnell, D., Greenland, H. L., Esfandiari, L., Timmerman, E., Foster, F., et al. (2022) · Medicine · doi:10.1097/md.0000000000030854 · Cited by 26
Zeng, F., Zhou, M., Li, Q., Hu, H., & Chen, C. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.08.001 · Cited by 12
Metadata
- Authors
- Sahu, M. R., & Mondal, A. C.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2019-11-08
- Volume
- 98
- Issue
- 5
- Pages
- 796-814
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2984562828
- Cited by
- 78
- References
- 23
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.